Seguir
Wenchao Wu
Wenchao Wu
Dirección de correo verificada de sysucc.org.cn
Título
Citado por
Citado por
Año
Circulating hematopoietic stem and progenitor cells are myeloid-biased in cancer patients
WC Wu, HW Sun, HT Chen, J Liang, XJ Yu, C Wu, Z Wang, L Zheng
Proceedings of the National Academy of Sciences 111 (11), 4221-4226, 2014
2092014
Spleen mediates a distinct hematopoietic progenitor response supporting tumor-promoting myelopoiesis
C Wu, H Ning, M Liu, J Lin, S Luo, W Zhu, J Xu, WC Wu, J Liang, CK Shao, ...
The Journal of clinical investigation 128 (8), 3425-3438, 2018
1302018
Transforming growth factor-β1-induced epithelial–mesenchymal transition generates ALDH-positive cells with stem cell properties in cholangiocarcinoma
ZY Shuang, WC Wu, J Xu, G Lin, YC Liu, XM Lao, L Zheng, S Li
Cancer letters 354 (2), 320-328, 2014
1142014
GLUT1 and ASCT2 as predictors for prognosis of hepatocellular carcinoma
HW Sun, XJ Yu, WC Wu, J Chen, M Shi, L Zheng, J Xu
PloS one 11 (12), e0168907, 2016
932016
Endothelium‐coated tumor clusters are associated with poor prognosis and micrometastasis of hepatocellular carcinoma after resection
T Ding, J Xu, Y Zhang, RP Guo, WC Wu, SD Zhang, CN Qian, L Zheng
Cancer 117 (21), 4878-4889, 2011
902011
Reprogramming immunosuppressive myeloid cells by activated T cells promotes the response to anti-PD-1 therapy in colorectal cancer
J Chen, HW Sun, YY Yang, HT Chen, XJ Yu, WC Wu, YT Xu, LL Jin, ...
Signal Transduction and Targeted Therapy 6 (1), 4, 2021
592021
Biomarker-driven strategy for MCL1 inhibition in T-cell lymphomas
R Koch, AL Christie, JL Crombie, AC Palmer, D Plana, K Shigemori, ...
Blood, The Journal of the American Society of Hematology 133 (6), 566-575, 2019
492019
An in situ molecular signature to predict early recurrence in hepatitis B virus-related hepatocellular carcinoma
J Xu, T Ding, Q He, XJ Yu, WC Wu, WH Jia, JP Yun, Y Zhang, M Shi, ...
Journal of hepatology 57 (2), 313-321, 2012
492012
Immunosuppressive Immature Myeloid Cell Generation Is Controlled by Glutamine Metabolism in Human CancerGlutaminolysis Controls IMC Generation in Cancers
WC Wu, HW Sun, J Chen, HY OuYang, XJ Yu, HT Chen, ZY Shuang, ...
Cancer immunology research 7 (10), 1605-1618, 2019
43*2019
Glutamine deprivation promotes the generation and mobilization of MDSCs by enhancing expression of G-CSF and GM-CSF
HW Sun, WC Wu, HT Chen, YT Xu, YY Yang, J Chen, XJ Yu, Z Wang, ...
Frontiers in immunology 11, 616367, 2021
222021
Retinoic acid synthesis deficiency fosters the generation of polymorphonuclear myeloid-derived suppressor cells in colorectal cancer
HW Sun, J Chen, WC Wu, YY Yang, YT Xu, XJ Yu, HT Chen, Z Wang, ...
Cancer Immunology Research 9 (1), 20-33, 2021
162021
Overcoming IMiD resistance in T-cell lymphomas through potent degradation of ZFP91 and IKZF1
W Wu, GM Nelson, R Koch, KA Donovan, RP Nowak, TB Heavican-Foral, ...
Blood, The Journal of the American Society of Hematology 139 (13), 2024-2037, 2022
122022
ITK degradation to block T cell receptor signaling and overcome therapeutic resistance in T cell lymphomas
B Jiang, DM Weinstock, KA Donovan, HW Sun, A Wolfe, S Amaka, ...
Cell Chemical Biology, 2023
42023
TP63 fusions drive multicomplex enhancer rewiring, lymphomagenesis, and EZH2 dependence
G Wu, N Yoshida, J Liu, X Zhang, Y Xiong, TB Heavican-Foral, E Mandato, ...
Science translational medicine 15 (714), eadi7244, 2023
12023
p120 RasGAP and ZO-2 are essential for Hippo signaling and tumor-suppressor function mediated by p190A RhoGAP
H Ouyang, S Wu, W Li, MJ Grey, W Wu, SH Hansen
Cell reports 42 (12), 2023
2023
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–15